PSEN1型
早老素
生物
炎症
免疫学
失调
结肠炎
癌症研究
肠道菌群
疾病
阿尔茨海默病
医学
内科学
作者
Lena Erkert,Reyes Gámez‐Belmonte,Melanie Kabisch,Lena Schödel,Jay V. Patankar,Miguel Gonzalez-Acera,Mousumi Mahapatro,Lili Bao,Christina Plattner,Anja A. Kühl,Jie Shen,Lutgarde Serneels,Bart De Strooper,Markus F. Neurath,Stefan Wirtz,Christoph Becker
出处
期刊:Gut
[BMJ]
日期:2024-04-29
卷期号:: gutjnl-331622
被引量:2
标识
DOI:10.1136/gutjnl-2023-331622
摘要
Objective Mutations in presenilin genes are the major cause of Alzheimer’s disease. However, little is known about their expression and function in the gut. In this study, we identify the presenilins Psen1 and Psen2 as key molecules that maintain intestinal homoeostasis. Design Human inflammatory bowel disease (IBD) and control samples were analysed for Psen1 expression. Newly generated intestinal epithelium-specific Psen1-deficient, Psen2-deficient and inducible Psen1/Psen2 double-deficient mice were used to dissect the functional role of presenilins in intestinal homoeostasis. Results Psen1 expression was regulated in experimental gut inflammation and in patients with IBD. Induced deletion of Psen1 and Psen2 in mice caused rapid weight loss and spontaneous development of intestinal inflammation. Mice exhibited epithelial barrier disruption with bacterial translocation and deregulation of key pathways for nutrient uptake. Wasting disease was independent of gut inflammation and dysbiosis, as depletion of microbiota rescued Psen-deficient animals from spontaneous colitis development but not from weight loss. On a molecular level, intestinal epithelial cells lacking Psen showed impaired Notch signalling and dysregulated epithelial differentiation. Conclusion Overall, our study provides evidence that Psen1 and Psen2 are important guardians of intestinal homoeostasis and future targets for barrier-promoting therapeutic strategies in IBD.
科研通智能强力驱动
Strongly Powered by AbleSci AI